Molecular Imaging

SNMMI awards $530K in Mars Shot grants

By AuntMinnie.com staff writers

The SNMMI Mars Shot Research Fund was established in 2023.

June 11, 2026

PSMA-PET/CT halves biopsy rate in prostate cancer patients

By Will Morton

A majority of men with equivocal findings on MRI are found on biopsy to have either no cancer or clinically insignificant disease.

June 11, 2026

Early FAPI-PET scans match 60-minute scans for lung cancer staging

By Will Morton

By convention, most molecular imaging tracers such as F-18 FDG are injected one hour prior to PET scans to allow time for uptake of the tracer by tumors.

June 10, 2026

RadioMedix wins FDA ANDA approval for Ga-68 PSMA-11 PET imaging agent

By AuntMinnie.com staff writers

Company highlights ANDA and FDA inspection.

June 10, 2026

Pentixapharm gets IND for Ga-68 pentixafor

By AuntMinnie.com staff writers

The PET agent shows promise distinguishing unilateral from bilateral disease in primary aldosteronism.

June 9, 2026

Memorial Sloan Kettering sues GE HealthCare over PET/CT patents

By AuntMinnie.com staff writers

The cancer center claims GE HealthCare's MotionFree technology was invented by a physicist at the institution.

June 8, 2026

What side effects do patients report after Pluvicto therapy?

By Will Morton

Fatigue, pain flare, nausea, and urinary symptoms are among the most commonly reported immediate side effects of Pluvicto therapy.

June 5, 2026

Brain SPECT offers insight into suicide risk

By Kate Madden Yee

Study results show that a single resting-state scan yields individualized risk trajectories that identify high-risk patients.

June 5, 2026

IAEA coordinates terbium radioisotope efforts for theranostics

By AuntMinnie.com staff writers

Terbium-based radiopharmaceuticals remain at an early stage.

June 5, 2026

SNMMI ShowCast Roundup

By Will Morton

Science was the star in Los Angeles at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.

June 5, 2026

PET reveals brain receptor deficits in schizophrenia

By Will Morton

The study confirms that deficits in M1 receptor are present in a subgroup of schizophrenia patients.

June 4, 2026

Radiopharmaceutical manufacturers report uneven FDA inspections

By Liz Carey

RMTA lays out radiopharmaceutical regulatory and payment policy issues.

June 4, 2026

Page 1 of 629

Next Page